Nichino America Inc v. Valent USA LLC

44 F.4th 180
CourtCourt of Appeals for the Third Circuit
DecidedAugust 12, 2022
Docket21-1850
StatusPublished
Cited by7 cases

This text of 44 F.4th 180 (Nichino America Inc v. Valent USA LLC) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nichino America Inc v. Valent USA LLC, 44 F.4th 180 (3d Cir. 2022).

Opinion

PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT ______________

No. 21-1850 ______________

NICHINO AMERICA, INC., Appellant

v.

VALENT U.S.A. LLC ______________

On Appeal from the United States District Court for the District of Delaware (D.C. No. 1-20-cv-00704) District Judge: Honorable Leonard P. Stark ______________

Argued March 22, 2022

Before: BIBAS, MATEY, and PHIPPS, Circuit Judges

(Filed: August 12, 2022) Bradley L. Cohn [Argued] Jacquelyn Prom Belinda J. Scrimenti Pattishall McAuliffe Newbury Hilliard & Geraldson 200 South Wacker Drive Suite 2900 Chicago, IL 60606 Counsel for Appellee Eric R. Clendening Flaster Greenberg 1810 Chapel Avenue West Cherry Hill, NJ 08002 Jordan A. LaVine [Argued] Flaster Greenberg Suite 1050 1717 Arch Street Suite 3300 Philadelphia, PA 19103 Counsel for Appellant ______________

OPINION OF THE COURT ______________

MATEY, Circuit Judge.

Whether a federal court may issue an injunction against an allegedly infringing trademark can be a bit confusing. Responding, Congress passed the Trademark Modernization

2 Act of 2020 (“TMA”).1 Nichino America Inc. says the District Court misapplied the TMA when it denied its motion for a preliminary injunction against Valent USA LLC’s allegedly infringing mark. Finding no reversible error in the District Court’s careful application of its discretion, we will affirm. Along the way, we explain how district courts should apply the rebuttable presumption of irreparable harm created by the TMA.

I.

A. The Marks

Nichino and Valent sell pesticides for farming. Since 2004, Nichino has offered a trademarked product known as “CENTAUR.” Valent trademarked a competing product called “SENSTAR” in 2019, giving it a logo resembling CENTAUR’s colors, fonts, and arrow artwork. Both pesticides are used in the same geographic areas against many of the same insects, and both are sold to farmers through distributors. But there are differences. SENSTAR comes as a liquid and uses a unique combination of two active chemicals. It costs $425 per gallon, and ships in cases containing four one-gallon containers. CENTAUR is manufactured as a solid and sold by the pallet, with each containing 622 pounds of pesticide packed into bags and cases, for $24 per pound. Yet the similarities were enough for Nichino to sue Valent for trademark infringement, and ask for a preliminary injunction against SENSTAR’s launch. A suit that would become one of the first to apply the newly effective TMA.

1 Pub. L. No. 116-260, H.R. 133, 116th Cong. subtit. B, §§ 221–26 (2020).

3 B. District Court Proceedings

Nichino argued that Valent’s use of the SENSTAR mark would create confusion among consumers, a necessary element in a trademark infringement claim. See A & H Sportswear, Inc. v. Victoria’s Secret Stores, Inc., 237 F.3d 198, 210 (3d Cir. 2000). Confusion, said Nichino, likely to harm its reputation and goodwill, warranting injunctive relief.2 That is where the TMA enters, creating a rebuttable presumption of irreparable harm favoring a plaintiff who has shown a likelihood of success on the merits of an infringement claim.3

The District Court found Nichino narrowly demonstrated its infringement claim would likely succeed, though “there is not an abundance of evidence of likelihood of confusion” between the products. (App. at 176.) The District Court reached that conclusion by consulting the “Lapp factors,” our nearly forty-year-old, ten-part, yet non-exhaustive inquiry that guides analysis of likely confusion. See Interpace

2 Injunctions require the familiar showing of a likelihood of success on the merits, irreparable harm that outweighs the burden on the nonmoving party, and benefit to the public interest. Kos Pharms., Inc. v. Andrx Corp., 369 F.3d 700, 708 (3d Cir. 2004). These burdens are all borne by Nichino. Ferring Pharms., Inc. v. Watson Pharms., Inc., 765 F.3d 205, 210 (3d Cir. 2014). 3 In relevant part, the TMA states that plaintiffs seeking an injunction “shall be entitled to a rebuttable presumption of irreparable harm . . . upon a finding of likelihood of success on the merits for a violation identified in this subsection in the case of a motion for a preliminary injunction or temporary restraining order.” Pub. L. No. 116-260 § 226(a).

4 Corp. v. Lapp, Inc., 721 F.2d 460, 462–63 (3d Cir. 1983); see also A & H Sportswear, Inc., 237 F.3d at 213 (prescribing use of the Lapp factors in all trademark cases).4 Weighing and balancing, the District Court tallied a final score of five factors favoring Nichino, two neutral, and three “very important factors” (overall degree of similarity, consumers’ purchasing habits, and Valent’s intent in selecting the mark) in Valent’s column. (App. at 161–76.) Bringing us to the TMA, which the District Court applied to presume Nichino would suffer irreparable harm without an injunction. But that presumption is rebuttable, and the District Court credited Valent’s evidence of a sophisticated consumer class that makes careful purchases, and noted the lack of any evidence of actual consumer confusion. Closing the circle, the District Court found Nichino failed to proffer evidence that it would likely suffer irreparable

4 The factors summarized in Lapp break into three categories. First, facts about the plaintiff’s mark, including its distinctiveness. Second, facts about the defendant’s actions, including whether the mark was adopted to intentionally compete, overlapping sales and marketing efforts, and how long the competing mark has been in the market without confusion. Third, facts about how consumers deal with both marks. Is there evidence of actual confusion, or do costs and other differences between the goods make confusion unlikely? See Lapp, 721 F.2d at 463–64 (holding that trial court adequately addressed “every relevant area of inquiry” without “formally apply[ing]” the factors when it made findings about “[t]he plaintiff’s mark,” how “the defendant markets its products,” and “[f]inally and perhaps most important,” what “customers in the [relevant] field would find [] natural or likely” about which company makes which product).

5 harm without immediate injunctive relief.5 Finally, the District Court held that the balance of equities and public interest weigh against issuing a preliminary injunction.

For those reasons, the District Court denied the injunction, and Nichino appealed, challenging the Court’s finding that Valent had rebutted the presumption of irreparable harm.6 Finding no reversible error that disturbs the District Court’s conclusion, we will affirm.7

II.

Nichino contends that the TMA precluded the District Court’s decision about irreparable harm. But the District Court admirably navigated Congress’ newly minted rebuttable presumption. While our discussion builds on the District Court’s insights, we arrive at the same conclusion. Valent

5 Here, the District Court appropriately cited Nichino’s evidence of likely consumer confusion. Evidence of consumer confusion is relevant to both likelihood of success and irreparable harm, so the evidence that plaintiffs offer to show one will often also tend to show the other. See Kos Pharms., Inc., 369 F.3d at 726 (highlighting the importance of consumer confusion to both inquiries). 6 The District Court had jurisdiction under 28 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
44 F.4th 180, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nichino-america-inc-v-valent-usa-llc-ca3-2022.